ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients
Clinical trial NCT01464827 · COMPLETED
Trial details
- NCT number
- NCT01464827
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-03-01
- Enrollment
- 580
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.